What inhaler therapies are appropriate for patients with chronic interstitial lung disease?

Inhaled Therapies Are Generally Not Recommended for Chronic Interstitial Lung Disease

Inhaled corticosteroids should NOT be routinely prescribed for chronic ILD, and there is no established role for traditional bronchodilator inhalers in treating the underlying disease process. 1

Key Evidence Against Routine Inhaler Use

Inhaled Corticosteroids

• For pulmonary sarcoidosis with chronic cough: inhaled corticosteroids are specifically NOT recommended (Grade 2C recommendation) 1
• Recent population data suggests high-dose inhaled corticosteroids (≥1000 µg/day) may actually be associated with increased IPF risk (adjusted HR: 3.89-3.99), though causality is unclear 2
• No guideline evidence supports inhaled corticosteroids for treating ILD itself

The Exception: Inhaled Treprostinil for Pulmonary Hypertension

The only FDA-approved inhaled therapy relevant to ILD is inhaled treprostinil, but this treats a specific complication, not the ILD itself:

• Approved for Group 3 pulmonary hypertension associated with ILD (PH-ILD) 3
• Up to 85% of patients with end-stage fibrotic ILD develop pulmonary hypertension 4
• Improves walking distance and respiratory symptoms in this subset 4, 3
• This is NOT a treatment for ILD—it's for the pulmonary hypertension complication

What Actually Works for ILD

Disease-Modifying Therapy

First-line treatment depends on ILD subtype:

• IPF and progressive pulmonary fibrosis: Nintedanib or pirfenidone (oral antifibrotics, not inhalers) reduce FVC decline by 44-57% 4
• Connective tissue disease-ILD: Immunomodulators like mycophenolate mofetil, rituximab, or tocilizumab 5, 4

Symptomatic Management

For the troublesome cough that affects up to 80% of ILD patients:

1. First assess for: ILD progression, drug side effects, pulmonary infection, or typical cough causes (GERD, post-nasal drip) 1
2. For refractory cough: Gabapentin (neuromodulator) or multimodality speech pathology therapy 1
3. Last resort: Opiates for palliative symptom control when quality of life is severely affected 1

Critical Pitfalls to Avoid

• Do not prescribe PPIs for IPF cough if GERD workup is negative 1
• Do not use inhaled corticosteroids thinking they will help inflammation—they don't work for ILD-associated cough 1
• Do not confuse inhaled treprostinil (for PH-ILD complication) with treatment for ILD itself
• Avoid long-term systemic glucocorticoids for ILD progression; reserve only for short-term bridging 5

The Bottom Line

Traditional inhalers (bronchodilators, inhaled steroids) have no role in treating chronic ILD. The disease requires oral antifibrotics for IPF/PPF or immunomodulators for CTD-ILD. The only inhaled therapy with evidence is treprostinil, and only for patients who develop pulmonary hypertension as a complication—not for the ILD itself.